Back to search
Mucocutaneous Lymph Node Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mucocutaneous Lymph Node Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Mucocutaneous Lymph Node Syndrome trials you may qualify forThe study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and…
Kawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant…
Based on a population pharmacokinetic model-based dose optimization study, a 15 mg-equivalent, age-, and bodyweight-adjusted dosing regimen for Chinese children…
Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to the accelerated aging o…
Based on population pharmacokinetic model-based simulation, a 15 mg-equivalent, age-, and bodyweight-adjusted dosing regimen for Chinese children with giant cor…
This study evaluates the efficacy of the addition of prednisolone to conventional initial treatment (intravenous immunoglobulin \[IVIG\] plus aspirin) in reduci…
The goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Kawasaki disease (KD) children complicated…
The aim of present study is to determine cardiovascular status of children who had KD in past and to identify possible biochemical markers of cardiovascular dam…